Cowealth Medical Holding Co (ROCO:4745) ROCE %: -11.71% (As of Dec. 2025)


ROCO:4745 Cowealth Medical Holding Co Ltd ROCO:4745
50 GF Score
Price NT$13.80
GF Value NT$13.11
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Cowealth Medical Holding Co ROCE %?

Cowealth Medical Holding Co ROCO:4745 50 ROCE % is -11.71% as of Dec. 2025. GuruFocus rates ROCO:4745 with a GF Score™ of 50/100 and a GF Value™ of NT$13.11 (Fairly Valued). The stock has 6 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Cowealth Medical Holding Co's annualized ROCE % for the quarter that ended in Dec. 2025 was -11.71%.

Cowealth Medical Holding Co  (ROCO:4745) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Cowealth Medical Holding Co ROCE % Related Terms

Cowealth Medical Holding Co ROCE % Historical Data

* Premium members only.

The historical data trend for Cowealth Medical Holding Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cowealth Medical Holding Co ROCE % Chart

Cowealth Medical Holding Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.90 9.22 5.67 2.30 -5.11

Cowealth Medical Holding Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.38 -3.62 -2.35 -3.74 -11.71
ROCO:4745
50GF Score
Cowealth Medical Holding Co Ltd ROCO:4745
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cowealth Medical Holding Co ROCE % Calculation

Cowealth Medical Holding Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-262.573/( ( (6958.441 - 1753.431) + (7042.105 - 1974.743) )/ 2 )
=-262.573/( (5205.01+5067.362)/ 2 )
=-262.573/5136.186
=-5.11 %

Cowealth Medical Holding Co's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Sep. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Sep. 2025 )(Q: Dec. 2025 )
=-573.076/( ( (6650.136 - 1928.458) + (7042.105 - 1974.743) )/ 2 )
=-573.076/( ( 4721.678 + 5067.362 )/ 2 )
=-573.076/4894.52
=-11.71 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -11.71% mean?
Cowealth Medical Holding Co (ROCO:4745) has a ROCE % of -11.71% as of Dec. 2025.
Is Cowealth Medical Holding Co's ROCE % too high?
Cowealth Medical Holding Co's current ROCE % is -11.71%. Overall, Cowealth Medical Holding Co has a GF Score™ of 50/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cowealth Medical Holding Co's ROCE % compare to ABT and SYK?
Cowealth Medical Holding Co's ROCE % of -11.71% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.30. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.30, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cowealth Medical Holding Co's current ROCE % is -11.71%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cowealth Medical Holding Co stock overvalued right now?
Based on GuruFocus' analysis, Cowealth Medical Holding Co (ROCO:4745) is currently considered Fairly Valued. The stock's GF Value™ is NT$13.11, compared to a current price of NT$13.80 — trading 5.3% above its estimated fair value. The current ROCE % is -11.71%. Cowealth Medical Holding Co's overall GF Score™ is 50/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Cowealth Medical Holding Co (ROCO:4745), the current ROCE % is -11.71% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cowealth Medical Holding Co (ROCO:4745) Overvalued in 2026?

Based on GuruFocus' analysis, Cowealth Medical Holding Co stock appears to be overvalued. The current stock price of NT$13.80 is trading 5.3% above its estimated GF Value™ of NT$13.11. GuruFocus considers Cowealth Medical Holding Co to be Fairly Valued.

Key valuation signals for ROCO:4745:

  • ROCE %: -11.71%
  • GF Value™: NT$13.11 vs. price of NT$13.80 (5.3% above fair value)
  • GF Score™: 50/100 with 6 warning signs

No single metric tells the full story. See the ROCO:4745 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cowealth Medical Holding Co Business Description

Address North Sound Road, Suite 102, Cannon Place, P.O. Box 712, George Town, Grand Cayman, CYM, KY1-9006
Cowealth Medical Holding Co Ltd is mainly involved in trading medical equipment, reagents, and spare parts. Its wide range of solutions includes refined management services tailored for in-vitro diagnostic products, reagents, and consumables, an integrated platform designed for decision-making and analysis, commercialization of achievements in medical science and technology, a Multi-Channel Coaxial Time Audio Video Imaging Platform (MCCTAVIP), and an AI-assisted system for clinical diagnosis. The Group has two reportable segments: Segment A, which generates maximum revenue and sells equipment, and Segment B, which sells reagents and others. Geographically, it generates maximum revenue from China and Hong Kong, and the rest from Taiwan.
50GF Score

Get the complete analysis for ROCO:4745

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$13.80
Price
NT$13.11
GF Value